Titelia

Funds holding Shenzhen Hepalink Pharmaceutical Group Co Ltd

ISIN CNE100003YN2 · China

Fund holders
18
Of which ETFs
7 11 other funds
Value held
1.3M $ 5.4M SEK
FundSharesValueWeight in fund
Handelsbanken Global Index Criteria Handelsbanken Fonder AB 912,0005.4M SEK0.00 %as of Mar 31, 2026 ↗
EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 749,000464.4K $0.00 %as of Apr 30, 2026 ↗
DIMENSIONAL EMERGING MARKETS VALUE FUND DIMENSIONAL EMERGING MARKETS VALUE FUND 265,500164.6K $0.00 %as of Apr 30, 2026 ↗
THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO 238,000147.6K $0.00 %as of Apr 30, 2026 ↗
Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust 225,000139K $0.00 %as of Apr 30, 2026 ↗
Dimensional Emerging Core Equity Market ETF Dimensional ETF Trust 154,00095.1K $0.00 %as of Apr 30, 2026 ↗
Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust 94,50058.4K $0.00 %as of Apr 30, 2026 ↗
Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 85,00052.7K $0.00 %as of Apr 30, 2026 ↗
Dimensional Emerging Markets Value ETF Dimensional ETF Trust 75,50046.6K $0.00 %as of Apr 30, 2026 ↗
World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 69,00042.8K $0.00 %as of Apr 30, 2026 ↗
Goldman Sachs MarketBeta Total International Equity ETF Goldman Sachs ETF Trust II 44,50029.9K $0.00 %as of Feb 27, 2026 ↗
Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 41,50025.7K $0.00 %as of Apr 30, 2026 ↗
World ex U.S. Targeted Value Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 23,50014.6K $0.00 %as of Apr 30, 2026 ↗
Emerging Markets Targeted Value Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 23,00014.3K $0.00 %as of Apr 30, 2026 ↗
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS 20,00012.4K $as of Apr 30, 2026 ↗
VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS 15,5009.6K $as of Apr 30, 2026 ↗
Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF DBX ETF Trust 14,3319.6K $0.02 %as of Feb 27, 2026 ↗
Dimensional Emerging Markets Sustainability Core 1 ETF Dimensional ETF Trust 14,0008.6K $0.00 %as of Apr 30, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF DBX ETF Trust 0.02 %as of Feb 27, 2026 ↗
Goldman Sachs MarketBeta Total International Equity ETF Goldman Sachs ETF Trust II 0.00 %as of Feb 27, 2026 ↗
Emerging Markets Targeted Value Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026 ↗
THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO 0.00 %as of Apr 30, 2026 ↗
Handelsbanken Global Index Criteria Handelsbanken Fonder AB 0.00 %as of Mar 31, 2026 ↗
Dimensional Emerging Markets Value ETF Dimensional ETF Trust 0.00 %as of Apr 30, 2026 ↗
Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026 ↗
Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026 ↗
Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust 0.00 %as of Apr 30, 2026 ↗
World ex U.S. Targeted Value Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q21702,151,831+2.8 %
2026Q11702,092,945+9.2 %
2025Q417+31,916,445+22.5 %
2025Q314+11,564,000+45.6 %
2025Q21301,074,500-26.2 %
2025Q11301,455,000+1.8 %
2024Q413+11,429,736+40.2 %
2024Q312+21,019,736-17.3 %
2024Q210+21,233,680-18.7 %
2024Q18-101,516,605-48.1 %
2023Q4182,920,901
Cite this page

Titelia. "Funds holding Shenzhen Hepalink Pharmaceutical Group Co Ltd". https://titelia.com/en/stocks/shenzhen-hepalink-pharmaceutical-group-co-ltd-CNE100003YN2